Luteolin displayed a stronger apoptosis on undifferentiated myeloid leukemia cells with higher PTTG1 expression levels than on PMA- or ATRA-differentiated cells with lower PTTG1 expression levels. The gene discussed is PTTG1; the disease is myeloid leukemia.